REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,395,855 | -1.2% | 23,498 | -11.9% | 0.00% | 0.0% |
| Q1 2023 | $2,424,201 | +165.1% | 26,663 | +10.8% | 0.00% | – |
| Q4 2022 | $914,420 | +44.2% | 24,070 | -4.5% | 0.00% | – |
| Q3 2022 | $634,000 | -9.8% | 25,204 | +8.9% | 0.00% | – |
| Q2 2022 | $703,000 | -3.7% | 23,142 | +3.9% | 0.00% | – |
| Q1 2022 | $730,000 | +24.1% | 22,282 | -0.1% | 0.00% | – |
| Q4 2021 | $588,000 | -73.7% | 22,300 | +0.2% | 0.00% | -100.0% |
| Q3 2021 | $2,238,000 | -7.4% | 22,253 | +30.4% | 0.00% | 0.0% |
| Q2 2021 | $2,416,000 | +45.4% | 17,067 | +2.4% | 0.00% | 0.0% |
| Q1 2021 | $1,662,000 | -16.1% | 16,665 | +4.0% | 0.00% | 0.0% |
| Q4 2020 | $1,980,000 | +7.4% | 16,021 | -15.3% | 0.00% | 0.0% |
| Q3 2020 | $1,843,000 | -37.8% | 18,916 | -0.4% | 0.00% | 0.0% |
| Q2 2020 | $2,963,000 | +46.1% | 18,991 | +35.1% | 0.00% | 0.0% |
| Q1 2020 | $2,028,000 | -25.2% | 14,054 | +6.0% | 0.00% | 0.0% |
| Q4 2019 | $2,711,000 | +234.3% | 13,259 | +31.2% | 0.00% | – |
| Q3 2019 | $811,000 | +115.7% | 10,107 | +154.0% | 0.00% | – |
| Q2 2019 | $376,000 | +19.4% | 3,979 | +7.8% | 0.00% | – |
| Q1 2019 | $315,000 | +64.1% | 3,691 | +8.1% | 0.00% | – |
| Q4 2018 | $192,000 | -23.2% | 3,414 | +11.5% | 0.00% | – |
| Q3 2018 | $250,000 | +190.7% | 3,062 | +24.2% | 0.00% | – |
| Q2 2018 | $86,000 | +115.0% | 2,465 | +25.3% | 0.00% | – |
| Q1 2018 | $40,000 | -53.5% | 1,968 | -36.0% | 0.00% | – |
| Q4 2017 | $86,000 | -19.6% | 3,075 | -10.3% | 0.00% | – |
| Q3 2017 | $107,000 | +37.2% | 3,429 | +39.2% | 0.00% | – |
| Q2 2017 | $78,000 | +254.5% | 2,464 | +155.9% | 0.00% | – |
| Q1 2017 | $22,000 | +69.2% | 963 | +56.3% | 0.00% | – |
| Q4 2016 | $13,000 | – | 616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |